Acknowledgements The authors would like to thank Thomas Rohban, MD, and Magalie El Hajj, PharmD, from Partner 4 Health (Paris, France) for providing medical writing support in accordance with Good Publication Practice (GPP3) guidelines
As for mortality, both SGLT-2 inhibitors and GLP-1RA are similar in reducing both total and CV deaths, but SGLT-2 inhibitors only are superior to DPP-4 inhibitors for both deaths, whereas GLP-1RA are superior to DPP-4 inhibitors for total death, but equal for CV death
Favorable regulatory approvals and clinical trial success rates are accelerating market expansion
Take the tablet daily on an empty stomach with no more than 4 oz (120 mL) plain water, then wait at least 30 minutes before eating, drinking, or taking other oral medications
15.2.18 TEVA PHARMACEUTICAL INDUSTRIES LTD